Association between predictor variables and development of neurological complications among COVID-19 patients. حسب Javaria Aslam (13864104)

Supplementary Material for: Adjunctive active vitamin D (AVD) decreases kidney function during treatment of secondary hyperparathyroidism (SHPT) with extended-release calcifediol (... حسب figshare admin karger (2628495)

Relative change and 95% confidence intervals in overall, urogenital, anorectal and oropharyngeal chlamydia and gonorrhoea testing among GPs in Amsterdam after participation in an e... حسب Saskia Bogers (14322197)

Maternal Transfer of 2‑Ethylhexyl Diphenyl Phosphate Leads to Developmental Toxicity Possibly by Blocking the Retinoic Acid Receptor and Retinoic X Receptor in Japanese Medaka (Ory... حسب Yu Li (183836)

"…After adult female medaka were exposed to EHDPP at 156, 405, and 1161 ng/L for 35 days, the embryonic EHDPP concentrations (364–4824 ng/g lipid weight (lw)) were higher than those in the maternal tissues (15.0–4166 ng/g lw), showing notable maternal transfer. …"

Inhibition of pan- and HDAC isoform activities. حسب Mira Jung (1277502)

"…Pharmacokinetic evaluation demonstrates an area under the curve (AUC) of 5227.55 ng/ml × h with an elimination half-life of 1.26 h following intravenous administration in a rat model. …"

Data Sheet 1_Effect of threonine level in a high-protein diet on the growth performance and carcass characteristics of 50- to 91-day-old slow-growing indigenous male Boschveld chic... حسب Tebogo Mack Sekgotodi (22465483)

Antibodies used for flow cytometry experiments. حسب Joseph Rabin (7399436)

"…RA was devoid of serious side effects, and within 24 hours from the start of infusion was associated with increased oxygen saturation (93.8 ± 0.58 vs 96.6 ± 1.08%, P<0.05), decreased D-dimer (754 ± 17 vs 518 ± 98 ng/ml, P<0.05), and a trend toward decreased CRP (3.80 ± 1.40 vs 1.98 ± 0.74 mg/dL, P = 0.075). …"

Subject flow diagram. حسب Joseph Rabin (7399436)

"…RA was devoid of serious side effects, and within 24 hours from the start of infusion was associated with increased oxygen saturation (93.8 ± 0.58 vs 96.6 ± 1.08%, P<0.05), decreased D-dimer (754 ± 17 vs 518 ± 98 ng/ml, P<0.05), and a trend toward decreased CRP (3.80 ± 1.40 vs 1.98 ± 0.74 mg/dL, P = 0.075). …"

Size distributions of ucfDNA molecules. حسب Meihui Chen (1670020)

Analysis of ucfDNA in DHSs between control and age-comparable bladder cancer groups. حسب Meihui Chen (1670020)

Effects of TGF-β1 on the expression of fibrosis indicators in HBdSMCs and the effects of MEL on the expression of fibrosis indicators in HBdSMCs induced by TGF-β1. حسب Yang Zhang (30734)

VANGL2 recruits MARCH8 to promote the K27-linked ubiquitination of NLRP3. حسب Huaji Jiang (16907514)

VANGL2 recruits NLRP3 to OPTN for selective autophagic degradation. حسب Huaji Jiang (16907514)

Fig 6 - حسب Hyun-Jun Kim (1561153)

"…D) qPCR analysis of iNOS expression in C2C12 myotubes treated with 50 or 100 ng/mL TNF-α for 24 h. **** = <i>p</i><0.0001 indicate significantly decreased viability compared to the untreated control. …"

Fig 2 - حسب Hyun-Jun Kim (1561153)

"…Myoblasts were differentiated for 72 h and treated with 10 μM Dex, or 10 μM Dex plus 300 nM or 600 nM Ni or 50 ng/ml bovine insulin for 24 h. B) Average diameter of C2C12 myotubes treated with Dex or Dex+Ni. *** = <i>p</i><0.001 indicate significantly decreased compared to the untreated control. ### = <i>p</i><0.001 to indicate significantly increased myotube diameter compared to Dex treated myotubes. …"

Fig 4 - حسب Hyun-Jun Kim (1561153)

"…B) Representative images of myosin heavy chain immunostained C2C12 cultures after treatment with 150 nM, 300 nM,600 nMNi and 50 ng/ml bovine insulin for 48 h (the size bar = 100 μm). …"

Loop in the IB domain drives ParM monomer opening. حسب Natalie Ng (6560246)

Cell line characterization and combination effect of KRAS G12C inhibitors and pemigatinib. حسب Angela Abdollahi (15166230)

PRV UL4 augments ASC oligomerization and speck formation. حسب Xiaohua Zhang (350570)

Knockdown of the β2-AR fails to prevent carvedilol-mediated inhibition of EGF-induced neoplastic transformation of JB6 P+ cells. حسب Kristan H. Cleveland (6714539)